Cargando…

EV71 vaccines: a milestone in the history of global vaccine development

Detalles Bibliográficos
Autor principal:	Lu, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008769/ https://www.ncbi.nlm.nih.gov/pubmed/26038519 http://dx.doi.org/10.1038/emi.2014.29

Ejemplares similares

Production of EV71 vaccine candidates
por: Chong, Pele, et al.
Publicado: (2012)

Progress on the research and development of inactivated EV71 whole-virus vaccines
por: Liang, Zheng-Lun, et al.
Publicado: (2013)

EV71 vaccine, an invaluable gift for children
por: Liang, Zhenglun, et al.
Publicado: (2014)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Milestones in history of adult vaccination in Korea
por: Oh, Myoung-don, et al.
Publicado: (2012)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
por: Lim, Hui Xuan, et al.
Publicado: (2019)

Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine
por: Liu, Longding, et al.
Publicado: (2013)

Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines
por: Ng, Qingyong, et al.
Publicado: (2015)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
por: Gao, Wenying, et al.
Publicado: (2020)

Inactivated enterovirus A71 vaccines and moving forward
por: Shimizu, Hiroyuki
Publicado: (2021)

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice
por: Mao, Qunying, et al.
Publicado: (2012)

Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
por: Liu, Pei, et al.
Publicado: (2021)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China
por: Guo, Wei, et al.
Publicado: (2022)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

A timely update of global COVID-19 vaccine development
por: Klavinskis, Linda S., et al.
Publicado: (2020)

The global fight to develop antipoverty vaccines in the anti-vaccine era
por: Hotez, Peter J.
Publicado: (2018)

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
por: Mao, Qunying, et al.
Publicado: (2016)

Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils
por: Sun, Yi-Sheng, et al.
Publicado: (2019)

Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine
por: Yang, Bingyi, et al.
Publicado: (2017)

Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71
por: Varma, Nadimpalli Ravi S., et al.
Publicado: (2013)

Immune Efficacy of the EV71 Vaccine in Fujian Province, China: A Real-World Analysis of HFMD
por: Li, Junrong, et al.
Publicado: (2023)

Commentary: A milestone forgotten
por: Austin, Erle H.
Publicado: (2021)

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
por: Van Gool, Stefaan W., et al.
Publicado: (2023)

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
por: Wu, Chia-Ying, et al.
Publicado: (2019)

Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China
por: Meng, Xiao-Dan, et al.
Publicado: (2020)

Effect of difference between EV-A71 virus epidemic strain and “vaccine strain” on neutralizing antibody titer
por: Ding, Yiwei, et al.
Publicado: (2022)

Preclinical safety evaluation of a bivalent inactivated EV71-CA16 vaccine in mice immunized intradermally
por: Liao, Yun, et al.
Publicado: (2023)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2014)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Correction: Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
Publicado: (2014)

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge
por: Wang, Xiaowen, et al.
Publicado: (2016)

COVID-19 vaccine development: milestones, lessons and prospects
por: Li, Maochen, et al.
Publicado: (2022)

Inhibition of EV71 by curcumin in intestinal epithelial cells
por: Huang, Hsing-I, et al.
Publicado: (2018)

Leading Enterovirus Genotypes Causing Hand, Foot, and Mouth Disease in Guangzhou, China: Relationship with Climate and Vaccination against EV71
por: Du, Zhicheng, et al.
Publicado: (2021)

Comparing the Primary and Recall Immune Response Induced by a New EV71 Vaccine Using Systems Biology Approaches
por: Shao, Jie, et al.
Publicado: (2015)

Surveillance, Epidemiology and Impact of EV-A71 Vaccination on Hand, Foot, and Mouth Disease in Nanchang, China, 2010–2019
por: He, Fenglan, et al.
Publicado: (2022)

Milestone M7.1: Completion of the ISOLDE yield database
por: Schmidt, K. H
Publicado: (10/0)

Cannot write session to /tmp/vufind_sessions/sess_h1ofukg32jm93593fdtna58c61